1. Placebo group risk of admission/length of stay.
Study | Placebo group ‐ participants | Placebo group ‐ primary outcomes | |
OUTPATIENT STUDIES | Risk of admission day 1 (%) | Risk of admission day 7 (%) | |
Barlas 1998 | 30 | 17% | NR |
Berger 1998 | 18 | 11% | NR |
Corneli 2007 | 295 | 41% | 49% |
Goebel 2000 | 24 | 8% | 21% |
Kuyucu 2004 | 11 | 0% | 0% |
Mesquita 2009 | 32 | 22% | NR |
Plint 2009 | 201 | 18% | 26% |
Schuh 2002 | 34 | 44% | 47% |
INPATIENT STUDIES | Length of stay (mean ± SD days) | ||
Bentur 2005 | 32 | 6.3 ± 8.8 | |
Cade 2000 | 79 | 2 ± 2.2 | |
De Boeck 1997 | 15 | 6.6 ± 1.2 | |
Gomez 2007 | 25 | 0.8 ± 0.2 | |
Klassen 1997 | 32 | 2 ± 0.7 | |
Richter 1998 | 19 | 3 ± 1.6 | |
Teeratakulpisarn 2007 | 85 | 2.8 ± 1.7 | |
Zhang 2003 | 24 | 5 ± 3.3 |
NR = not reported SD = standard deviation